相关实验视频

Updated: May 5, 2026

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis

Published on: May 1, 2015

在复发性/耐药性多发性骨髓瘤中使用莱纳利多米德的三胞胎:分析捷克骨髓瘤组的分析

Jiri Minarik¹, Ludek Pour², Vojtech Latal³

¹Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Olomouc, Czech Republic. abretina@email.cz.

|April 9, 2025

概括

基于达拉图穆马布 (DRD) 的三重疗法在复发性/耐药性多发性骨髓瘤 (RRMM) 中,与卡菲尔佐米布 (KRD) 和伊克萨佐米布 (IRD) 疗法相比,在现实世界中表现出更好的疗效. 在RRMM患者中,DRD实现了更高的应答率和更长的无进展生存期.

科学领域:

血液学血液学血液学
在瘤学瘤学.
临床研究临床研究

背景情况:

多发性骨髓瘤 (MM) 治疗已取得进展,但复发仍然很常见,需要新的治疗策略.
基于莱纳利多米德 (LEN) 的三重疗法是复发性/耐药性多发性骨髓瘤 (RRMM) 的标准.
在临床试验之外评估治疗有效性的现实数据至关重要.

研究的目的:

在RRMM患者中比较基于lenalidomide的三种三重疗法的现实有效性.
具体比较达拉图穆马布 (DRD),卡菲尔佐米布 (KRD) 和伊克萨佐米布 (IRD) 疗法.
评估整体应答率 (ORR),无进展生存率 (PFS) 和整体生存率 (OS).

主要方法:

对538名RRMM患者进行了基于注册表的回顾性研究.
对接受治疗治疗第一到第三次复发的患者的分析.
经匹配调整的间接比较 (MAIC) 用于调整队列差异.

主要成果:

达拉图马布 (DRD) 显示出最高的ORR (91.4%) 和最长的PFS中位数 (23.64个月).
卡菲尔佐米布 (KRD) 的ORR为89.6%,PFS为16.52个月.
伊克萨佐米布 (IRD) 疗法具有较低的ORR (70.8%-79.6%) 和较短的PFS (11.57-19.97个月).
MAIC证实DRD治疗方案的优异结果.
任何基于莱纳利多米德的疗法都无法克服高风险特征.

结论:

基于达拉图马布 (DRD) 的三重疗法在实现RRMM患者持续反应方面优越.
现实世界的证据强调了治疗成分和队列因素的重要性.
这项研究强调了现实世界的数据在临床实践中评估治疗模式的价值.

关键词:

莱纳利多米德三胞胎多发性骨髓瘤是一种多发性骨髓瘤.复发 / 耐火性复发 / 耐火性风险组风险组风险组风险组

更多相关视频

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs

Published on: May 15, 2019

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...